Rapport Therapeutics IPO Price Indicating $18.05 On 350,819 Shares; IPO Priced At $17 On 8M Shares
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics has set its IPO price at $17 per share for 8 million shares, with an initial trading price indicating $18.05 on 350,819 shares.
June 07, 2024 | 2:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rapport Therapeutics has priced its IPO at $17 per share for 8 million shares, with an initial trading price indicating $18.05 on 350,819 shares. This suggests strong initial demand and potential positive short-term price movement.
The IPO pricing at $17 and the initial trading price indicating $18.05 suggest strong demand for Rapport Therapeutics shares. This is likely to result in a positive short-term price movement as investors show interest in the new offering.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100